Is Applied Molecular Transport Inc. (AMTI) a Buy, Sell, or Hold?
NASDAQ : AMTI
Applied Molecular Transport Inc.
$0.263 USD
-$0.01 (-3.13%)
- Volume
- 235.21K
- Average Volume
- 316.86K
- Market Capitalization
- $11.01M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- $1.70
- Year High
- $0.84
- Year Low
- $0.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.24
Company Overview
NASDAQ
Shawn M. Cross
Biotechnology
Healthcare
AMTI
13
US
USD
Liquidity Metrics
0.59
4.24
4.24
4.05
0.00
Sales & Valuation
-$
0.00
0.17
-0.11
-2.52
Profitability
-$3.23
-$125.43M
0.00%
0.00%
-111.78%
-116.74%
P/E Metrics
-0.08
0.00
0.00
Analyst Price Target & Rating
$1.70
$3.00
$0.40
0/5
5 Analysts
-84.53%
Financial Health Scores
-39.20
2/9
$15.04M
$20.02M
$3.78M
-$76.42M
Key Metrics (TTM)
-$14.02M
0.00
0.11
4.24
-111.78%
-129.95%
-1228.01%
-890.87%
0 days
Company Executives
| Name | Title |
|---|---|
| Andrew H. Chang | Head of Investor Relations & Corporation Communications |
Poll Results
No votes yet today — be the first to share your view!
About Applied Molecular Transport Inc. (NASDAQ:AMTI) Stock
Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California. The firm is dedicated to discovering and advancing a pipeline of oral and respiratory biologic drug candidates, designed to address a variety of medical conditions including autoimmune, inflammatory, and metabolic diseases. Among its investigational treatments, AMT-101 stands out as the lead candidate. This orally administered, gastrointestinal (GI)-selective biologic, derived from rhIL-10, is presently in Phase II clinical trials for the management of ulcerative colitis and other related inflammatory indications. AMTI is also further developing AMT-126, another oral, GI-selective biologic that harnesses interleukin 22. ... This compound is currently undergoing Phase I clinical studies for the treatment of disorders stemming from impaired intestinal epithelial barrier function. The company's innovative technology platform allows for the creation and development of a broad spectrum of oral biologic therapeutic approaches, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics.
Frequently Asked Questions
-
What is the current Applied Molecular Transport Inc. (AMTI) stock price?
-
Applied Molecular Transport Inc.(NASDAQ:AMTI) stock price is $0.263 in the last trading session. During the trading session, AMTI stock reached the peak price of $0.84 while $0.1343 was the lowest point it dropped to. The percentage change in AMTI stock occurred in the recent session was --3.13% while the dollar amount for the price change in AMTI stock was -$0.01.
-
AMTI's industry and sector of operation?
-
The NASDAQ listed AMTI is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AMTI?
-
Andrew H. Chang | Head of Investor Relations & Corporation Communications
|
|
|
| -
How many employees does AMTI have?
-
Number of AMTI employees currently stands at 13. AMTI operates from 450 East Jamie Court, South San Francisco, CA 94080, US.
-
Link for AMTI official website?
-
Official Website of AMTI is: https://www.appliedmt.com
-
How do I contact AMTI?
-
AMTI could be contacted at phone #650 392 0420 and can also be accessed through its website. AMTI operates from 450 East Jamie Court, South San Francisco, CA 94080, US.
-
How many shares of AMTI are traded daily?
-
The average number of AMTI shares traded daily for last 3 months was 316.86K.
-
What is the market cap of AMTI currently?
-
The market value of AMTI currently stands at $11.01M with its latest stock price at $0.263